Experimental drugs for the prevention or treatment of sensorineural hearing loss DOI Creative Commons

Judith Kempfle,

David H. Jung

Expert Opinion on Investigational Drugs, Journal Year: 2023, Volume and Issue: 32(7), P. 643 - 654

Published: July 3, 2023

Introduction Sensorineural hearing loss results in irreversible of inner ear hair cells and spiral ganglion neurons. Reduced sound detection speech discrimination can span all ages, sensorineural rehabilitation is limited to amplification with aids or cochlear implants. Recent insights into experimental drug treatments for regeneration otoprotection have paved the way clinical trials order restore a more physiological experience. Paired development innovative minimally invasive approaches delivery ear, new, emerging protection restoration are within reach.Areas covered This expert opinion provides an overview latest therapies protect from loss.Expert The degree type cellular damage cochlea, responsiveness remaining, endogenous regenerative treatments, duration availability fluids will determine success restoration.

Language: Английский

Loss of Mst1/2 activity promotes non-mitotic hair cell generation in the neonatal organ of Corti DOI Creative Commons
Xiaoling Lu, Huiqian Yu, Jiaoyao Ma

et al.

npj Regenerative Medicine, Journal Year: 2022, Volume and Issue: 7(1)

Published: Oct. 25, 2022

Mammalian sensory hair cells (HCs) have limited capacity for regeneration, which leads to permanent hearing loss after HC death. Here, we used in vitro RNA-sequencing show that the Hippo signaling pathway is involved damage and self-repair processes. Turning off through Mst1/2 inhibition or Yap overexpression induces YAP nuclear accumulation, especially supporting cells, supernumerary production regeneration injury. Mechanistically, these effects of work synergistically with Notch pathway. Importantly, HCs not only express markers, but also cilia structures are able form neural connections auditory regions vivo. Taken together, regulating suggests new strategies promoting cochlear cell proliferation, reconnection neurons mammals.

Language: Английский

Citations

11

Emerging therapies for human hearing loss DOI
Elise A. Ajay, Niliksha Gunewardene, Rachael T. Richardson

et al.

Expert Opinion on Biological Therapy, Journal Year: 2022, Volume and Issue: 22(6), P. 689 - 705

Published: April 29, 2022

More than 5% of the world's population have a disabling hearing loss which can be managed by aids or implanted electrical devices. However, outcomes are highly variable, and sound perceived recipients is far from perfect. Sparked discovery progenitor cells in cochlea rapid progress drug delivery to cochlea, biological pharmaceutical therapies currently development improve function cochlear implant eliminate need for it altogether.This review highlights emerging regenerative strategies restore adjunct augment implant. Novel approaches include reprogramming sensory hair cell gene therapy, editing treat hereditary acquired loss. A detailed optogenetics also presented as technique that could enable optical stimulation spiral ganglion neurons, replacing complementing stimulation.Increasing evidence substantial reversal animal models, alongside advances learnings clinical trials will amalgamate into therapy replace complement

Language: Английский

Citations

10

The regenerative capacity of neonatal tissues DOI Open Access
Angela M. Montero, Alice H. Huang

Development, Journal Year: 2022, Volume and Issue: 149(12)

Published: June 15, 2022

ABSTRACT It is well established that humans and other mammals are minimally regenerative compared with organisms such as zebrafish, salamander or amphibians. In recent years, however, the identification of potential in neonatal mouse tissues normally heal poorly adults has transformed our understanding capacity mammals. this Review, we survey mammalian for which improved healing been established, including heart, cochlear hair cells, brain spinal cord, dense connective tissues. We also highlight common and/or tissue-specific mechanisms regeneration, involve signaling pathways, extracellular matrix, immune cells factors. The features across may direct therapeutic strategies will be broadly applicable to multiple adult

Language: Английский

Citations

10

Craniofacial Development Is Fine-Tuned by Sox2 DOI Open Access

Nikolaos Mandalos,

A. Dimou,

Maria Angeliki Gavala

et al.

Genes, Journal Year: 2023, Volume and Issue: 14(2), P. 380 - 380

Published: Jan. 31, 2023

The precise control of neural crest stem cell delamination, migration and differentiation ensures proper craniofacial head development. Sox2 shapes the ontogeny cranial to ensure precision flow in developing head. Here, we review how orchestrates signals that these complex developmental processes.

Language: Английский

Citations

6

Experimental drugs for the prevention or treatment of sensorineural hearing loss DOI Creative Commons

Judith Kempfle,

David H. Jung

Expert Opinion on Investigational Drugs, Journal Year: 2023, Volume and Issue: 32(7), P. 643 - 654

Published: July 3, 2023

Introduction Sensorineural hearing loss results in irreversible of inner ear hair cells and spiral ganglion neurons. Reduced sound detection speech discrimination can span all ages, sensorineural rehabilitation is limited to amplification with aids or cochlear implants. Recent insights into experimental drug treatments for regeneration otoprotection have paved the way clinical trials order restore a more physiological experience. Paired development innovative minimally invasive approaches delivery ear, new, emerging protection restoration are within reach.Areas covered This expert opinion provides an overview latest therapies protect from loss.Expert The degree type cellular damage cochlea, responsiveness remaining, endogenous regenerative treatments, duration availability fluids will determine success restoration.

Language: Английский

Citations

6